Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-24-007077

CEO and CFO bought 12,700 shares at $11.07 ($140,589)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2024-02-15 Purchase +12,700 $11.07 $140,589 5,325,377 D
Open-market purchases · 12,700 sh · avg $11.07 · $140,589
Loading xslF345X05/ownership.xml…